Compile Data Set for Download or QSAR
Report error Found 77 Enz. Inhib. hit(s) with all data for entry = 12938
TargetMenin(Human)
Bala Therapeutics

US Patent
LigandPNGBDBM742435(4-methyl-1-[2-(4-methyl- sulfonyl-1,4-diazepan- 1-...)
Affinity DataEC50: <75nMAssay Description:Compound activity was determined using recombinant MEN1 protein (Creativebiomart, Cat #MEN1-35H) and a custom fluorescein-labeled MLL4-43 peptide (Et...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/19/2025
Entry Details
US Patent

TargetMenin(Human)
Bala Therapeutics

US Patent
LigandPNGBDBM742434(4-methyl-1-[(2S)-2- [(3S)-3-methyl-4- methylsulfon...)
Affinity DataEC50: <75nMAssay Description:Compound activity was determined using recombinant MEN1 protein (Creativebiomart, Cat #MEN1-35H) and a custom fluorescein-labeled MLL4-43 peptide (Et...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/19/2025
Entry Details
US Patent

TargetMenin(Human)
Bala Therapeutics

US Patent
LigandPNGBDBM742433(4-methyl-1-[(2R)-2- [(3S)-3-methyl-4- methylsulfon...)
Affinity DataEC50: <75nMAssay Description:Compound activity was determined using recombinant MEN1 protein (Creativebiomart, Cat #MEN1-35H) and a custom fluorescein-labeled MLL4-43 peptide (Et...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/19/2025
Entry Details
US Patent

TargetMenin(Human)
Bala Therapeutics

US Patent
LigandPNGBDBM742432(1-[(2S)-2-[(3S)-4- ethylsulfonyl-3-methyl- piperaz...)
Affinity DataEC50: <75nMAssay Description:Compound activity was determined using recombinant MEN1 protein (Creativebiomart, Cat #MEN1-35H) and a custom fluorescein-labeled MLL4-43 peptide (Et...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/19/2025
Entry Details
US Patent

TargetMenin(Human)
Bala Therapeutics

US Patent
LigandPNGBDBM742431(1-[(2R)-2-[(3S)-4- ethylsulfonyl-3-methyl- piperaz...)
Affinity DataEC50: <75nMAssay Description:Compound activity was determined using recombinant MEN1 protein (Creativebiomart, Cat #MEN1-35H) and a custom fluorescein-labeled MLL4-43 peptide (Et...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/19/2025
Entry Details
US Patent

TargetMenin(Human)
Bala Therapeutics

US Patent
LigandPNGBDBM742430(4-methyl-1-[(1S)- 1-methyl-2-(4- methylsulfonyl- p...)
Affinity DataEC50: <75nMAssay Description:Compound activity was determined using recombinant MEN1 protein (Creativebiomart, Cat #MEN1-35H) and a custom fluorescein-labeled MLL4-43 peptide (Et...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/19/2025
Entry Details
US Patent

TargetMenin(Human)
Bala Therapeutics

US Patent
LigandPNGBDBM742429(4-methyl-1-[(1R)- 1-methyl-2-(4- methylsulfonyl- p...)
Affinity DataEC50: <75nMAssay Description:Compound activity was determined using recombinant MEN1 protein (Creativebiomart, Cat #MEN1-35H) and a custom fluorescein-labeled MLL4-43 peptide (Et...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/19/2025
Entry Details
US Patent

TargetMenin(Human)
Bala Therapeutics

US Patent
LigandPNGBDBM742428(4-methyl-1-[(2-oxo-4- piperidyl) methyl]-5-[[2- [6...)
Affinity DataEC50: <75nMAssay Description:Compound activity was determined using recombinant MEN1 protein (Creativebiomart, Cat #MEN1-35H) and a custom fluorescein-labeled MLL4-43 peptide (Et...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/19/2025
Entry Details
US Patent

TargetMenin(Human)
Bala Therapeutics

US Patent
LigandPNGBDBM742442(4-methyl-1-[2-(4- methylsulfonyl- piperazin-1- yl)...)
Affinity DataEC50: <75nMAssay Description:Compound activity was determined using recombinant MEN1 protein (Creativebiomart, Cat #MEN1-35H) and a custom fluorescein-labeled MLL4-43 peptide (Et...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/19/2025
Entry Details
US Patent

TargetMenin(Human)
Bala Therapeutics

US Patent
LigandPNGBDBM742441(4-methyl-1- [4-(4-methyl- sulfonylpiperazin-1- yl)...)
Affinity DataEC50: <75nMAssay Description:Compound activity was determined using recombinant MEN1 protein (Creativebiomart, Cat #MEN1-35H) and a custom fluorescein-labeled MLL4-43 peptide (Et...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/19/2025
Entry Details
US Patent

TargetMenin(Human)
Bala Therapeutics

US Patent
LigandPNGBDBM742440(4-methyl-1- [2-(4-methyl- sulfonylpiperazin-1- yl)...)
Affinity DataEC50: <75nMAssay Description:Compound activity was determined using recombinant MEN1 protein (Creativebiomart, Cat #MEN1-35H) and a custom fluorescein-labeled MLL4-43 peptide (Et...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/19/2025
Entry Details
US Patent

TargetMenin(Human)
Bala Therapeutics

US Patent
LigandPNGBDBM742438(N-(1R,4R)-[4-[2-cyano- 4-methyl-5-[[2-[6- (2,2,2-t...)
Affinity DataEC50: <75nMAssay Description:Compound activity was determined using recombinant MEN1 protein (Creativebiomart, Cat #MEN1-35H) and a custom fluorescein-labeled MLL4-43 peptide (Et...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/19/2025
Entry Details
US Patent

TargetMenin(Human)
Bala Therapeutics

US Patent
LigandPNGBDBM742436(5-[[2-[7-fluoro- 6-(2,2,2- trifluoroethyl) quinazo...)
Affinity DataEC50: <75nMAssay Description:Compound activity was determined using recombinant MEN1 protein (Creativebiomart, Cat #MEN1-35H) and a custom fluorescein-labeled MLL4-43 peptide (Et...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/19/2025
Entry Details
US Patent

TargetMenin(Human)
Bala Therapeutics

US Patent
LigandPNGBDBM742419(5-[[2-[5-fluoro- 6-(2,2,2- trifluoroethyl) quinazo...)
Affinity DataEC50: <75nMAssay Description:Compound activity was determined using recombinant MEN1 protein (Creativebiomart, Cat #MEN1-35H) and a custom fluorescein-labeled MLL4-43 peptide (Et...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/19/2025
Entry Details
US Patent

TargetMenin(Human)
Bala Therapeutics

US Patent
LigandPNGBDBM742417(4-methyl-1-[(6-methyl- 5-oxo-morpholin-2- yl)methy...)
Affinity DataEC50: <75nMAssay Description:Compound activity was determined using recombinant MEN1 protein (Creativebiomart, Cat #MEN1-35H) and a custom fluorescein-labeled MLL4-43 peptide (Et...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/19/2025
Entry Details
US Patent

TargetMenin(Human)
Bala Therapeutics

US Patent
LigandPNGBDBM742415(4-methyl-1-[(7- oxoazepan-4-yl) methyl]-5-[[2- [6-...)
Affinity DataEC50: <75nMAssay Description:Compound activity was determined using recombinant MEN1 protein (Creativebiomart, Cat #MEN1-35H) and a custom fluorescein-labeled MLL4-43 peptide (Et...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/19/2025
Entry Details
US Patent

TargetMenin(Human)
Bala Therapeutics

US Patent
LigandPNGBDBM742414(4-methyl-1-[(2- oxohexahydro- pyrimidin-5- yl)meth...)
Affinity DataEC50: <75nMAssay Description:Compound activity was determined using recombinant MEN1 protein (Creativebiomart, Cat #MEN1-35H) and a custom fluorescein-labeled MLL4-43 peptide (Et...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/19/2025
Entry Details
US Patent

TargetMenin(Human)
Bala Therapeutics

US Patent
LigandPNGBDBM742413(4-methyl-1-[2-(2- oxoimidazolidin- 1-yl)ethyl]- 5-...)
Affinity DataEC50: <75nMAssay Description:Compound activity was determined using recombinant MEN1 protein (Creativebiomart, Cat #MEN1-35H) and a custom fluorescein-labeled MLL4-43 peptide (Et...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/19/2025
Entry Details
US Patent

TargetMenin(Human)
Bala Therapeutics

US Patent
LigandPNGBDBM742412(4-methyl-1-[(3-oxo- 1,4-oxazepan-7- yl)methyl]-5- ...)
Affinity DataEC50: <75nMAssay Description:Compound activity was determined using recombinant MEN1 protein (Creativebiomart, Cat #MEN1-35H) and a custom fluorescein-labeled MLL4-43 peptide (Et...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/19/2025
Entry Details
US Patent

TargetMenin(Human)
Bala Therapeutics

US Patent
LigandPNGBDBM742427(1-[(3,3-dioxo-1,3,4- oxathiazinan- 6-yl)methyl]- 4...)
Affinity DataEC50: <75nMAssay Description:Compound activity was determined using recombinant MEN1 protein (Creativebiomart, Cat #MEN1-35H) and a custom fluorescein-labeled MLL4-43 peptide (Et...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/19/2025
Entry Details
US Patent

TargetMenin(Human)
Bala Therapeutics

US Patent
LigandPNGBDBM742426(6-methoxy-1- [2-(4-methyl- sulfonylpiperazin-1- yl...)
Affinity DataEC50: <75nMAssay Description:Compound activity was determined using recombinant MEN1 protein (Creativebiomart, Cat #MEN1-35H) and a custom fluorescein-labeled MLL4-43 peptide (Et...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/19/2025
Entry Details
US Patent

TargetMenin(Human)
Bala Therapeutics

US Patent
LigandPNGBDBM742425(1-[2-(4-cyclopropyl- sulfonylpiperazin-1- yl)propy...)
Affinity DataEC50: <75nMAssay Description:Compound activity was determined using recombinant MEN1 protein (Creativebiomart, Cat #MEN1-35H) and a custom fluorescein-labeled MLL4-43 peptide (Et...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/19/2025
Entry Details
US Patent

TargetMenin(Human)
Bala Therapeutics

US Patent
LigandPNGBDBM742424(1-[2-(4-butyl- sulfonyl- piperazin-1- yl)propyl]-4...)
Affinity DataEC50: <75nMAssay Description:Compound activity was determined using recombinant MEN1 protein (Creativebiomart, Cat #MEN1-35H) and a custom fluorescein-labeled MLL4-43 peptide (Et...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/19/2025
Entry Details
US Patent

TargetMenin(Human)
Bala Therapeutics

US Patent
LigandPNGBDBM742423(4-methyl-1-[(4- methyl-3,3-dioxo-1,3,4- oxathiazin...)
Affinity DataEC50: <75nMAssay Description:Compound activity was determined using recombinant MEN1 protein (Creativebiomart, Cat #MEN1-35H) and a custom fluorescein-labeled MLL4-43 peptide (Et...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/19/2025
Entry Details
US Patent

TargetMenin(Human)
Bala Therapeutics

US Patent
LigandPNGBDBM742422(4-methyl-1-[(4- methyl-5-oxo- morpholin-2- yl)meth...)
Affinity DataEC50: <75nMAssay Description:Compound activity was determined using recombinant MEN1 protein (Creativebiomart, Cat #MEN1-35H) and a custom fluorescein-labeled MLL4-43 peptide (Et...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/19/2025
Entry Details
US Patent

TargetMenin(Human)
Bala Therapeutics

US Patent
LigandPNGBDBM742421(4-methyl-1-[(6- oxo-1H-pyridin-3- yl)methyl]- 5-[[...)
Affinity DataEC50: <75nMAssay Description:Compound activity was determined using recombinant MEN1 protein (Creativebiomart, Cat #MEN1-35H) and a custom fluorescein-labeled MLL4-43 peptide (Et...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/19/2025
Entry Details
US Patent

TargetMenin(Human)
Bala Therapeutics

US Patent
LigandPNGBDBM742420(4-methyl-1- [1-methyl-3-(4- methylsulfonyl- pipera...)
Affinity DataEC50: <75nMAssay Description:Compound activity was determined using recombinant MEN1 protein (Creativebiomart, Cat #MEN1-35H) and a custom fluorescein-labeled MLL4-43 peptide (Et...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/19/2025
Entry Details
US Patent

TargetMenin(Human)
Bala Therapeutics

US Patent
LigandPNGBDBM742466(4-methyl-1- [(2S)-2-(4- methylsulfonyl- piperazin-...)
Affinity DataEC50: <75nMAssay Description:Compound activity was determined using recombinant MEN1 protein (Creativebiomart, Cat #MEN1-35H) and a custom fluorescein-labeled MLL4-43 peptide (Et...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/19/2025
Entry Details
US Patent

TargetMenin(Human)
Bala Therapeutics

US Patent
LigandPNGBDBM742465(1-[2-(4-ethylsulfonyl- piperazin-1-yl) propyl]-4- ...)
Affinity DataEC50: <75nMAssay Description:Compound activity was determined using recombinant MEN1 protein (Creativebiomart, Cat #MEN1-35H) and a custom fluorescein-labeled MLL4-43 peptide (Et...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/19/2025
Entry Details
US Patent

TargetMenin(Human)
Bala Therapeutics

US Patent
LigandPNGBDBM742464(1-[2-(4-butylsulfonyl- 1,4-diazepan-1- yl)propyl]-...)
Affinity DataEC50: <75nMAssay Description:Compound activity was determined using recombinant MEN1 protein (Creativebiomart, Cat #MEN1-35H) and a custom fluorescein-labeled MLL4-43 peptide (Et...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/19/2025
Entry Details
US Patent

TargetMenin(Human)
Bala Therapeutics

US Patent
LigandPNGBDBM742463(4-methyl-1-[(6-oxo-3- piperidyl) methyl]-5-[[2- [6...)
Affinity DataEC50: <75nMAssay Description:Compound activity was determined using recombinant MEN1 protein (Creativebiomart, Cat #MEN1-35H) and a custom fluorescein-labeled MLL4-43 peptide (Et...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/19/2025
Entry Details
US Patent

TargetMenin(Human)
Bala Therapeutics

US Patent
LigandPNGBDBM742462(4-methyl-1-[2- (4-methyl- sulfonylpiperazin-1- yl)...)
Affinity DataEC50: <75nMAssay Description:Compound activity was determined using recombinant MEN1 protein (Creativebiomart, Cat #MEN1-35H) and a custom fluorescein-labeled MLL4-43 peptide (Et...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/19/2025
Entry Details
US Patent

TargetMenin(Human)
Bala Therapeutics

US Patent
LigandPNGBDBM742461(4-methyl-1-[1- methyl-2-(4- methylsulfonyl- pipera...)
Affinity DataEC50: <75nMAssay Description:Compound activity was determined using recombinant MEN1 protein (Creativebiomart, Cat #MEN1-35H) and a custom fluorescein-labeled MLL4-43 peptide (Et...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/19/2025
Entry Details
US Patent

TargetMenin(Human)
Bala Therapeutics

US Patent
LigandPNGBDBM742460(4-methyl-5- [[2-[6-(2,2,2- trifluoroethyl) quinazo...)
Affinity DataEC50: <75nMAssay Description:Compound activity was determined using recombinant MEN1 protein (Creativebiomart, Cat #MEN1-35H) and a custom fluorescein-labeled MLL4-43 peptide (Et...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/19/2025
Entry Details
US Patent

TargetMenin(Human)
Bala Therapeutics

US Patent
LigandPNGBDBM742475(4-methyl-1- [2-(4-methyl- sulfonylpiperazin-1- yl)...)
Affinity DataEC50: <75nMAssay Description:Compound activity was determined using recombinant MEN1 protein (Creativebiomart, Cat #MEN1-35H) and a custom fluorescein-labeled MLL4-43 peptide (Et...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/19/2025
Entry Details
US Patent

TargetMenin(Human)
Bala Therapeutics

US Patent
LigandPNGBDBM742474(4-methyl-1-[(5-oxo- 1,4-oxazepan-2- yl)methyl]-5- ...)
Affinity DataEC50: <75nMAssay Description:Compound activity was determined using recombinant MEN1 protein (Creativebiomart, Cat #MEN1-35H) and a custom fluorescein-labeled MLL4-43 peptide (Et...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/19/2025
Entry Details
US Patent

TargetMenin(Human)
Bala Therapeutics

US Patent
LigandPNGBDBM742471(4-methyl-1-[(5- oxomorpholin-2- yl)methyl]-5- [[2-...)
Affinity DataEC50: <75nMAssay Description:Compound activity was determined using recombinant MEN1 protein (Creativebiomart, Cat #MEN1-35H) and a custom fluorescein-labeled MLL4-43 peptide (Et...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/19/2025
Entry Details
US Patent

TargetMenin(Human)
Bala Therapeutics

US Patent
LigandPNGBDBM742470(4-methyl-1- [(2S)-2-(4- methylsulfonyl- piperazin-...)
Affinity DataEC50: <75nMAssay Description:Compound activity was determined using recombinant MEN1 protein (Creativebiomart, Cat #MEN1-35H) and a custom fluorescein-labeled MLL4-43 peptide (Et...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/19/2025
Entry Details
US Patent

TargetMenin(Human)
Bala Therapeutics

US Patent
LigandPNGBDBM742469(4-methyl-1- [2-(4-methyl- sulfonylpiperazin-1- yl...)
Affinity DataEC50: <75nMAssay Description:Compound activity was determined using recombinant MEN1 protein (Creativebiomart, Cat #MEN1-35H) and a custom fluorescein-labeled MLL4-43 peptide (Et...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/19/2025
Entry Details
US Patent

TargetMenin(Human)
Bala Therapeutics

US Patent
LigandPNGBDBM742451(N-[3-[2-cyano-4- methyl-5-[[2-[6-(2,2,2- trifluoro...)
Affinity DataEC50: <75nMAssay Description:Compound activity was determined using recombinant MEN1 protein (Creativebiomart, Cat #MEN1-35H) and a custom fluorescein-labeled MLL4-43 peptide (Et...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/19/2025
Entry Details
US Patent

TargetMenin(Human)
Bala Therapeutics

US Patent
LigandPNGBDBM742450(4-methyl-5-[[2-[2- (methylamino)- 6-(2,2,2- triflu...)
Affinity DataEC50: <75nMAssay Description:Compound activity was determined using recombinant MEN1 protein (Creativebiomart, Cat #MEN1-35H) and a custom fluorescein-labeled MLL4-43 peptide (Et...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/19/2025
Entry Details
US Patent

TargetMenin(Human)
Bala Therapeutics

US Patent
LigandPNGBDBM742449(5-[[2-[5- fluoro-6-(2,2,2- trifluoroethyl) quinazo...)
Affinity DataEC50: <75nMAssay Description:Compound activity was determined using recombinant MEN1 protein (Creativebiomart, Cat #MEN1-35H) and a custom fluorescein-labeled MLL4-43 peptide (Et...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/19/2025
Entry Details
US Patent

TargetMenin(Human)
Bala Therapeutics

US Patent
LigandPNGBDBM742448(1-[2-(4-ethylsulfonyl- 1,4-diazepan-1- yl)propyl]-...)
Affinity DataEC50: <75nMAssay Description:Compound activity was determined using recombinant MEN1 protein (Creativebiomart, Cat #MEN1-35H) and a custom fluorescein-labeled MLL4-43 peptide (Et...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/19/2025
Entry Details
US Patent

TargetMenin(Human)
Bala Therapeutics

US Patent
LigandPNGBDBM742447(4-methyl-1- [(5-oxopyrrolidin-2- yl)methyl]-5- [[2...)
Affinity DataEC50: <75nMAssay Description:Compound activity was determined using recombinant MEN1 protein (Creativebiomart, Cat #MEN1-35H) and a custom fluorescein-labeled MLL4-43 peptide (Et...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/19/2025
Entry Details
US Patent

TargetMenin(Human)
Bala Therapeutics

US Patent
LigandPNGBDBM742446(4-methyl-1- [(5-oxopyrrolidin- 3-yl)methyl]-5- [[2...)
Affinity DataEC50: <75nMAssay Description:Compound activity was determined using recombinant MEN1 protein (Creativebiomart, Cat #MEN1-35H) and a custom fluorescein-labeled MLL4-43 peptide (Et...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/19/2025
Entry Details
US Patent

TargetMenin(Human)
Bala Therapeutics

US Patent
LigandPNGBDBM742445(4-methoxy-1- [2-(4-methyl- sulfonylpiperazin-1- yl...)
Affinity DataEC50: <75nMAssay Description:Compound activity was determined using recombinant MEN1 protein (Creativebiomart, Cat #MEN1-35H) and a custom fluorescein-labeled MLL4-43 peptide (Et...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/19/2025
Entry Details
US Patent

TargetMenin(Human)
Bala Therapeutics

US Patent
LigandPNGBDBM742444(4-methoxy-1- [1-methyl-2-(4- methylsulfonyl- piper...)
Affinity DataEC50: <75nMAssay Description:Compound activity was determined using recombinant MEN1 protein (Creativebiomart, Cat #MEN1-35H) and a custom fluorescein-labeled MLL4-43 peptide (Et...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/19/2025
Entry Details
US Patent

TargetMenin(Human)
Bala Therapeutics

US Patent
LigandPNGBDBM742459(4-methyl-1- [2-(4-methyl- sulfonylpiperazin-1- yl)...)
Affinity DataEC50: <75nMAssay Description:Compound activity was determined using recombinant MEN1 protein (Creativebiomart, Cat #MEN1-35H) and a custom fluorescein-labeled MLL4-43 peptide (Et...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/19/2025
Entry Details
US Patent

TargetMenin(Human)
Bala Therapeutics

US Patent
LigandPNGBDBM742458(4-methyl-1-[3-(4-prop- 2-enoylpiperazin-1- yl)prop...)
Affinity DataEC50: <75nMAssay Description:Compound activity was determined using recombinant MEN1 protein (Creativebiomart, Cat #MEN1-35H) and a custom fluorescein-labeled MLL4-43 peptide (Et...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/19/2025
Entry Details
US Patent

TargetMenin(Human)
Bala Therapeutics

US Patent
LigandPNGBDBM742457(4-methyl-1-[4-(4-prop- 2-enoylpiperazin-1- yl)buty...)
Affinity DataEC50: <75nMAssay Description:Compound activity was determined using recombinant MEN1 protein (Creativebiomart, Cat #MEN1-35H) and a custom fluorescein-labeled MLL4-43 peptide (Et...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/19/2025
Entry Details
US Patent

Displayed 1 to 50 (of 77 total ) | Next | Last >>
Jump to: